Michelle Everill

Michelle Everill possesses extensive experience in the pharmaceutical industry, currently serving as VP of Global Trial Optimization at Alnylam Pharmaceuticals. Michelle is the Owner, CEO, Coach, and Speaker at Michelle Everill Coaching LLC, as well as the Owner, CEO, Consultant, and Speaker at Action From Data. Previous roles include Sr. Director and Head of Clinical Business Operations at Bristol Myers Squibb, and Sr. Director and Head of Global Feasibility at The Janssen Pharmaceutical Companies of Johnson & Johnson. Michelle Everill holds dual Bachelor of Science degrees in Economics and Behavioral Science and Health from the University of Utah, completed between 2000 and 2007.